Redhill Biopharma Ltd. (RDHL) vs cbdMD, Inc. (YCBD)
- Redhill Biopharma Ltd. RDHL 0.48 −4.00%
- cbdMD, Inc. YCBD 0.35 −2.78%
Redhill Biopharma Ltd. and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. Redhill Biopharma Ltd. and cbdMD, Inc. are of similar size ($4.4M and $4.0M). Redhill Biopharma Ltd. has negative trailing earnings, so its P/E is not meaningful; cbdMD, Inc. trades at 41.2×. cbdMD, Inc. grew revenue faster over the last twelve months: 10.0% against −61.9%. Redhill Biopharma Ltd. has the higher net margin (25.2% vs −14.7%) and the higher return on invested capital (0.00% vs −29.8%). Across the 16 metrics below, Redhill Biopharma Ltd. leads on 9 and cbdMD, Inc. on 7.
Valuation
Profitability
| Metric | RDHL | YCBD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 35.16% | 57.68% | 53.94% |
| Operating margin | 0.00% | (13.87%) | 0.00% |
| Net margin | 25.20% | (14.71%) | 0.00% |
| Free cash flow margin | 0.00% | (11.51%) | 0.00% |
| Return on equity | 0.00% | (43.01%) | (0.40%) |
| Return on assets | 0.00% | (26.73%) | (3.32%) |
| Return on invested capital | 0.00% | (29.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack